As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
A former NAB employee has taken the bank to court alleging her employment offer was rescinded after her boss discovered she was pregnant.
A judge has approved the discontinuance of a class action against a Westpac subsidiary after the funder bowed out.
A Fair Work Commission decision has cleared the way for former Tabcorp CEO Adam Rytenskild to pursue an unfair dismissal claim against the betting giant.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
CBA has attacked two failed class actions’ “misguided” appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.
The Full Court has heard that a judge’s finding on materiality in two failed shareholder class actions against CBA could have “troubling” repercussions for insider trading cases and must be overturned.
Coles and Woolworths face a possible second class action over alleged dodgy discounts the subject of enforcement action by the consumer watchdog.
Two failed class actions against CBA claim a judge used a “far too onerous test” for materiality in deciding whether the bank should have told the market about deficiencies in its anti-money laundering systems.
The corporate watchdog is suing the second Big Four bank in two months, alleging NAB mishandled hundreds of hardship applications from vulnerable customers.